Key result
NT-proBNP ≥80 pg/ml in men is linked to ~361% greater odds of high systolic blood pressure.
Why the study?
Is NT-proBNP associated with metabolic risk factors in subjects undergoing health examinations?
Cross-Sectional (n=11,508)
No
Is NT-proBNP associated with metabolic risk factors in subjects undergoing health examinations?
Odds Ratio: 4.61 (95% CI 2.64–8.02)
p-value: p=<0.01
NT-proBNP levels are independently associated with metabolic risk factors such as systolic blood pressure, fasting plasma glucose, and total cholesterol, suggesting its potential utility in assessing cardiovascular morbidity.
May flag metabolic risk in screened adults; hypothesis-generating for NT-proBNP in cardiovascular morbidity assessment.
INTRODUCTION: It has been shown that B type natriuretic peptide (BNP) level can indicate cardiovascular disease. However, the association between BNP and metabolic risk factors is unknown. The aim of this study was to investigate the correlation between N-terminal pro-B type natriuretic peptide (NT-proBNP) and metabolic risk factors. MATERIAL AND METHODS: A total of 11,508 subjects were selected from those who underwent health examinations in our hospital. NT-proBNP, waist circumference, blood pressure, fasting plasma glucose and lipid profile were measured. The level of NT-proBNP was measured and classified into four stratifications (BNP ≥ 20 pg/ml, ≥ 40 pg/ml, ≥ 60 pg/ml, and ≥ 80 pg/ml) to analyze the relationship between BNP and metabolic risk factors. RESULTS: B type natriuretic peptide increased gradually with increasing age (p < 0.001). The BNP levels were significantly higher in women than in men (p < 0.001). Multivariate regression analysis showed a positive association between NT-proBNP levels and systolic blood pressure (p < 0.001), fasting plasma glucose (p < 0.05), and total cholesterol (p < 0.001 in women). The NT-proBNP levels were inversely associated with diastolic blood pressure, waist circumference, triglyceride, high-density lipoprotein, and LDL cholesterol. Logistic regression analysis demonstrated a close relationship between NT-proBNP and systolic blood pressure, fasting plasma glucose, and total cholesterol. In the BNP ≥ 60 pg/ml group, odds ratio (OR) values were 1.80, 1.56 and 1.54 (female) and 3.74, 1.59 and 1.51 (male), respectively. In the BNP ≥ 80 pg/ml group, OR values were 2.45, 1.65 and 1.84 (female) and 4.61, 1.66 and 1.75 (male), respectively. CONCLUSIONS: NT-proBNP was independently associated with the main metabolic risk factors (systolic blood pressure, fasting plasma glucose, and total cholesterol). These findings suggest that the combined determination of NT-proBNP and the main metabolic risk factors could be important in assessing cardiovascular morbidity.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2016) conducted a cross-sectional in Metabolic risk factors (n=11,508). Elevated NT-proBNP levels vs. Lower NT-proBNP levels (<20 pg/ml) was evaluated on Association between NT-proBNP ≥ 80 pg/ml and systolic blood pressure in men (OR 4.61, 95% CI 2.64-8.02, p=<0.01). Elevated NT-proBNP levels were independently associated with metabolic risk factors, showing the strongest correlation with systolic blood pressure in men with NT-proBNP ≥ 80 pg/ml (OR 4.61).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: